|
Programme
|
|
|---|---|
| Welcome Remarks by the Conference Chairpersons | |
| CHB Therapy 1 Chairs: Prof. Ed Gane, Prof. Rino Gani, |
|
| Challenges for CHB functional cure – Prof. Geoffrey Dusheiko View Bio |
|
| Endpoints for CHB Therapy – Prof. Markus Cornberg View Bio |
|
| CHB Therapy 2 Chairs: Dr. Rajneesh Kumar, Prof. Pietro Lampertico, Dr. Soek Siam Tan |
|
| Consolidating guidelines for CHB (Pre-recording) – Prof. Teerha Piratvisuth View Bio |
|
| New China guidelines for CHB (Pre-recording) – Prof. Jidong Jia View Bio |
|
| Expanding treatment groups for CHB – Prof. Henry Chan View Bio |
|
| CHB Therapy 1 and CHB Therapy 2 Combined Round table discussion | |
| Roche Morning Tea Symposium Expanding Horizons in HCC: Early Detection and Systemic Treatment Opportunities (View Details) |
|
| Opening Remarks – Dr. Wei Peng Yong |
|
| Improving Patient Survival and Care: Early HCC Screening and Diagnosis with PIVKA-II – Prof. Man Fung Yuen |
|
| MDT Case Discussion and Q&A: >> From Surveillance to Diagnosis: Insights into the PatientJourney >> Evolving Perspectives in the HCC Treatment Landscape All faculty – Moderator: Dr. Wei Peng Yong |
|
| Closing remarks – Dr. Wei Peng Yong |
|
| CHB Therapy 3 Chairs: Prof. MF Yuen, Dr. Yang Wei Lyn, Dr. Rinaldi Lesmana |
|
| Landscape of CHB cure therapies – Prof. Man Fung Yuen View Bio |
|
| Challenges in CHB management: stop or continue NA therapy? – Prof. Markus Cornberg View Bio |
|
| HDV in cirrhosis: Best management practices – Prof. Pietro Lampertico View Bio |
|
| Round table discussion | |
| Case Discussion:A case of Delta and HBV co-infection – Presenter: Dr. Zain Majid, Sindh Institute, Pakistan |
|
| Astra Zeneca Lunch Symposium Recent Advancements in HCC & BTC: What Hepatologists and Gastroenterologists Should Know? (View Details) |
|
| INTRODUCTION – Dr. George Goh (Chair) |
|
| Recent advances in Hepatocellular Carcinoma (HCC) – Dr. Chee Cheng Ean |
|
| Recent advances in Biliary Tract Cancer (BTC) – Dr. David Tai |
|
| Case Presentation on HCC from Indonesia, Discuss practice variations in treatment of BTC – Dr. Rinaldi Lesmana |
|
| Case Presentation on BTC from China, Discuss practice variations in treatment of BTC – Dr. Hui-Chuan Sun |
|
| Discussions and Q&A | |
| HCC Symposium Part 1 Chairs: Prof. Yock Young Dan (Singapore), Dr. George Goh (Singapore) |
|
| Risk stratification for HCC risk – Prof. Henry Chan View Bio |
|
| Emerging biomarkers for HCC screening – Prof. Simone Strasser View Bio |
|
| Spectrum of therapies for locoregional therapy (Pre-Recorded) – Prof. Masatoshi Kudo View Bio |
|
| Debate: Personalised therapy for small HCC: are we there yet? – YES Prof. Pierce Chow View Bio – NO Prof. Alfred Kow View Bio |
|
| Case discussion:Resection of Large HCC – Presenter: Dr. Gillie Anne D. Domingo, Makati Medical Center, Manila, Philippines |
|
| Free paper: Assessment of GALAD score for surveillance of hepatocellular carcinoma in Singapore – Dr Liou Wei Lun, Dept of Gastroenterology and Hepatology, Singapore General Hospital |
|
| Q&A | |
| Round Table Discussion | |
| Tea Break | |
| HCC Symposium Part 2 Chairs: Prof. Shadab Siddique & Dr. Mark Muthiah |
|
| Immunotherapy as adjuvant therapy after resection or ablation – Prof. Pierce Chow View Bio |
|
| Intermediate HCC: challenges in management (Pre-recorded) – Dr Raghav Sundar View Bio |
|
| Rescue Therapy for advanced HCC – Prof. Han Chong Toh View Bio |
|
| Advances in systemic therapy? – Dr Chee Cheng Ean View Bio |
|
| Case discussion – HCC infiltrated Portal Vein and Inferior Vena Cava – Dr Ahmad Yusran, MD, Hepatology Division, Department of Internal Medicine, Cipto Mangunkusumo General Hospital-Faculty of Medicine Universitas Indonesia, Indonesia |
|
| Round table discussion | |
| Liver Disease in South East Asia Forum –
Chairs: Prof. Chan Wah Kheong, Dr. Tan Poh Seng, A/Prof, Jason Chang, Panelists: Prof. Rino Gani, Dr. Soek Siam Tan, Dr. Khin Maung Win, Dr. Lee Guan Huei, Prof. Teerha Piratvisuth (8 mins each) Discussion |
|
SHC 2023 Scientific Programme
June, 2023
2
June, 2023
3
| Programme | |
|---|---|
| NASH Chairs: Prof. Yock Young Dan, Prof. Arun Sanyal, Dr. George Goh |
|
| Management of the NASH patient today – Prof. Vincent Wong View Bio |
|
| Pitfalls in histology interpretation in NASH? – Prof. Arun Sanyal View Bio |
|
| Optimising diet interventions for NASH – Prof. Chan Wah Kheong View Bio |
|
| Debate: NASH treatment– is all about weight loss – YES Prof. Shadab Siddiqui View Bio – NO Prof. Vincent Wong View Bio |
|
| End organ complications of NASH – Prof. Shadab Siddiqui View Bio |
|
| Free paper: Comparative efficacy of Fibrosis-4, liver stiffness measurement, and Fibroscan-AST score to predict major liver-related outcomes in non-alcoholic fatty liver disease: An international multicenter study – Dr. Yu Jun WONG, Singapore View Bio |
|
| Round table discussion | |
| Morning Tea Symposium | |
| Hot Topics in Hepatology Chairs: Prof. Vincent Wong, Prof. Khin Maung Win |
|
| Microbiome and Fatty Liver: the gut actually matters? – Dr. Jonathan Lee View Bio |
|
| HCV update: improving access to care – Dr. Soek Siam Tan View Bio |
|
| Immune checkpoint inhibitor hepatitis – Dr. Mark Muthiah View Bio |
|
| Case Discussion: Diagnostic Uncertainty in Autoimmune Liver Disease – Presenter: Dr. Darlene Raudhatul Bahri, Cipto Mangunkusumo Hospital, Jakarta, Indonesia |
|
| Q&A | |
| Lunch Symposium | |
| Advanced Liver Disease Chairs: Prof. Simone Strasser , Dr. Soek Siam Tan, Prof. Jason Chang |
|
| Window of opportunity for beta blockers in portal hypertension – Prof. Guadalupe Garcia-Tsao View Bio |
|
| Peri-operative management of the cirrhotic patient – Prof. Simone Strasser View Bio |
|
| Transplantation for ALF/ACLF – Prof. Ajay Duseja View Bio |
|
| Debate: Direct Oral Anti-Coagulation (DOAC) are appropriate in portal vein thrombosis – YES Prof. Guadalupe Garcia-Tsao View Bio – NO Prof. Rajender Reddy View Bio |
|
| Case discussion: Ascites in an adolescent –Presenter: Dr Arjun Maria Sir Ganga Ram Hospital, New Delhi, India |
|
| Round Table Discussion | |
| Tea Break | |
| Liver Transplantation Chairs: Prof. Rajender Reddy , Dr. Mark Muthiah, Prof. Ajay Duseja |
|
| Can immunosuppression be stopped post liver transplant – Prof. Simone Strasser View Bio |
|
| Downstaging HCC for liver transplant – Prof. Shridhar Iyer View Bio |
|
| Onco transplant: the new frontier – Prof. Glenn Bonney View Bio |
|
| Viewpoint: Liver transplant in the East versus the West – West Prof. Shadab Siddiqui View Bio – East Dr. Alfred Kow View Bio |
|
| Case discussion – Downstaging BCLC HCC – can transplant be considered? – Presenter: Dr Dinu Abirami P, Gleneagles Global Health City, Chennai, India. |
|
| Round table discussion | |
| Closing Comments | |
